The inevitable happened today, and Lifecell (LIFC) was bought out today by Kinetic. The stock had already been on a run of late and capped off its path with a 17% gain on today's news to $50 per share. LifeCell is a top supplier of tissue based products for reconstructive and other medical uses and its financials combined with lack of viable competition have provided shareholders with a masterful return over the years. Unfortunately, although I posted and recommend on multiple occasions as far back as June of 2007, LIFC didn't make it in to the Everyday Finance portfolio. This was an old investment club favorite back at $7 per share. I hope some readers were turned on to the stock and got to participate.